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Aim We report diverse phenotypic consequences of the delQKP-1507–1509 cardiac sodium channel
mutation in three generations of a Chinese family.
Methods and results Clinical and electrocardiographic (ECG), echocardiographic examination was fol-
lowed by direct sequencing of SCN5A, KCNQ1, HERG, and LAMIN A/C to screen genomic DNA from
blood samples. Of two mutation carriers, the proband was born with conduction disorders including
second-degree atrioventricular (AV) block with prolonged QTc interval, additionally showing left
anterior fascicular block (LAFB), incomplete right bundle-branch block (IRBBB), and intermittent
third-degree AV block at 2 years, and clinical presentations of multiple syncope despite normal electro-
encephalograms at 8 years. Continuous ECG monitoring following presentation at 13 years revealed
prolonged QTc and biphasic T-waves, multiple episodes of ventricular tachycardia, ventricular ﬁbrilla-
tion, and torsades de pointes. Transthoracal echocardiography then revealed left ventricular dilatation
and reduced systolic function. Another mutation carrier showed features of long QT syndrome type
3 (LQT3), LAFB, and dilated cardiomyopathy (DCM). Two additional subjects died suddenly at 13 and
33 years.
Conclusion This data compliments and expands the spectrum of phenotypes resulting from this known
gain-of-function mutation, including not only LQT3, cardiac conduction defects, and sudden death but
also DCM, hitherto associated with loss-of-function mutations, for the ﬁrst time.
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Introduction
Mutations in SCN5A encoding the a-subunit of the human
cardiac sodium channel have been associated with an
increasingly wide range of cardiac rhythm disorders that
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Europace (2008) 10, 1329–1335
doi:10.1093/europace/eun202include not only the long QTsyndrome type 3 (LQT3) but also
the Brugada syndrome (BrS), cardiac conduction diseases,
idiopathic ventricular ﬁbrillation, sinus node dysfunction
including sick sinus syndrome (SSS), atrial standstill,
dilated cardiomyopathy (DCM), and sudden infant death syn-
drome, each characterized by distinct electrocardiographic
(ECG) and clinical features.
1–6 Single, speciﬁc, SCN5A
mutations can thus each result in either single or multiple
phenotypes.
Mutations in SCN5A leading to LQT3 are in general associ-
ated with a gain-of-channel function with increased late
sodium current leading to a delayed repolarization and pro-
longed action potentials. The ﬁrst and the most extensively
studied mutation in LQT3 has been the deletion of three
amino acids KPQ at positions 1505–1507 in the cardiac
sodium channel.
7,8 Similarly, deletions of the three amino
acid residues delQKP at position1507–1509 sharing the
deletion of Q1507 with the delKPQ exclusively resulted
in the same LQT3 phenotype.
9 These mutations located in
the DIII–DIV linker region of the cardiac sodium channel
involve the inactivation process of the channel.
10
The present study has identiﬁed a delQKP mutation at
position 1507–1509 of the cardiac sodium channel through
three generations of a Chinese family associated with an
expanded spectrum of disorders: LQT3, cardiac conduction
defects, DCM, and high incidence of youth sudden death.
It also excluded possible mutations that would lead to
amino acid changes in KCNQ1, HERG, and LAMIN A/C com-
monly associated with LQT1, LQT2, and DCM with con-
duction disorders on earlier occasions.
11–13 The data thus
compliments and expands the spectrum of phenotypes
resulting from this known mutation, and associates the
DCM phenotype with gain, and not only loss of sodium
channel function for the ﬁrst time.
Methods
Clinical investigation
All investigations conformed to principles deﬁned in the Helsinki
Declaration. Eleven members of a three-generation Chinese family
were investigated (Figure 1), informed written consent having
been obtained from each member. They included a complete
medical history, physical examination, at least two 12-lead ECG
recordings obtained at different times and echocardiographic scan-
ning. Heart rates, widths of P wave, PR intervals, QRS durations, and
QT intervals corrected for heart rate using Bazett’s formula (QTc)
were measured in limb lead II. QTc intervals were averaged from
ﬁve consecutive beats of at least two 12-lead ECG recordings at
different time points. Resting echocardiography was performed
by experts. Global function was digitized using an IE33 system
(Philips Medical Systems, Eindhoven, The Netherlands) with
1–5 MHz broadband phased-array transducer connected. Biplane
end-diastolic and end-systolic volumes were calculated from the
planimetered areas by computer software according to a modiﬁed
Simpson’s rule. Two hundred unrelated control individuals were ran-
domly selected from a group of Chinese healthy volunteers with
normal 12-lead ECGs and without reported cardiovascular history.
SCN5A mutation analysis
Genomic DNA was extracted from 10 mL of whole blood using the
Puregene Isolation kit (Gentra Systems, USA). The coding regions
of SCN5A, KCNQ1, HERG, and LAMIN A/C and their exon–intron
boundaries were ampliﬁed from genomic DNA by polymerase chain
reaction (PCR) using a comprehensive set of primers and PCR con-
ditions as described previously.
7,13,14 Bidirectional sequencing was
performed by an ABI automated cycle sequencer using an ABI
BigDye Terminator Cycle Sequencing Kit (Applied Biosystems,
USA). Sequencing results were aligned with the respective wild-type
sequences to detect genetic variations. The identiﬁed mutation was
screened among the remaining family members by direct DNA
sequencing. The mutations were further veriﬁed by single strand
conformational polymorphism analysis (SSCP). The same mutation
was also screened among 200 controls with the same ethnic
background.
Results
Clinical features in the proband
The proband (Figure 1, subject III-2) is a 13-year-old
girl, who was diagnosed with a cardiac conduction disorder
identiﬁed as second-degree (Mobitz type II) atrioventricular
(AV) block, prolonged QTc, and AV junctional ectopic beats,
by a 12-lead ECG at 40 days after birth with heart rates
ranging from 60 to 120 bpm. Further assessment at
2 months had revealed a bradycardic heart rate of 75 bpm,
QTc prolongation, left axis deviation, and left anterior fasci-
cular block (LAFB). At 4 months, she showed an atrial rate of
125 bpm and a third-degree AV block with a ventricular rate
of 60 bpm. At the end of 2 years of life, the ECG conduction
abnormalities consisted of a 2:1 second-degree AV block
with intermittent episodes of third-degree AV block in suc-
cessive ECG recordings, but an absence of signiﬁcant atrial
or ventricular arrhythmias. However, she did not present
again with symptoms until 8 years of age, when she pre-
sented with a history of multiple episodes of syncope and
seizure triggered by ﬁts of anger that persisted over the
subsequent 5 years, despite being normal to electro-
encephalographic examination. The episodes occurred
reproducibly and were short-lived and followed by prompt
and complete recovery. She also had recurrent nocturnal
dyspnoeic episodes over this period.
At the end of this period, she was a paediatric cardio-
logical patient, presenting with multiple episodes of syncope
and seizure. Within hours following admission, continuous
ECG monitoring during such multiple episodes led to a diag-
nosis of ventricular ﬁbrillation and torsade de pointe (TdP)
Figure 1 Pedigree information of the family with the SCN5A-
delQKP1507–1509 mutation. Filled squares denote affected male;
ﬁlled circles denote affected female; open squares denote unaf-
fected males; open circles denote unaffected females; pen square
with a slash indicates deceased because of liver cancer; ﬁlled
circles/square with a slash indicates sudden death and genotypes
consequently are not available. Arrows indicate the proband.
R. Shi et al. 1330Figure 2 Twelve-lead electrocardiography (ECG) and transthoracal echocardiography results of proband. (A) 12-lead ECG (25 mm/s). Leads
I, II, III, aVR, aVL, aVF (10 mm/mV), and V1–V6 (5 mV/mm) showed prolonged QTc, with the former showing biphasic Twaves, and the latter
alternating upright and inverting T-waves (T-wave alternans). ECG records also show intraventricular conduction delay of left anterior fasci-
cular block (LAFB) and incomplete right bundle-branch block (IRBBB). (B) An example of an episode of torsades de pointes. (C) Transthoracal
echocardiographic image demonstrating dilated left ventricle by apex position. (D) Colour Doppler image showed dysfunction of the left ven-
tricular wall (wall velocity approximately 4.35 cm/s).
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12-lead ECG recording revealed a sinus rate with a relative
risk interval of 680 ms, which on some follow-up measure-
ments increased to as much as 1132 ms. In addition, there
was a borderline PR interval (200 ms) and normal QRS
durations (100 ms), features of intraventricular conduction
delay consisting of LAFB and incomplete right bundle-branch
block (IRBBB). QTc interval was prolonged (750 ms) and
T-waves were biphasic with a delayed onset (Figure 2A).
Continuous ECG monitoring revealed self-terminating
episodes of TdP (Fig. 2B). Transthoracic echocardiography
revealed a LV dilatation with end-diastolic and end-systolic
volumes (LVEDV and LVESV) of 156 mL and 98 mL, respect-
ively, low ejection fraction (EF) of 37% (Table 1) and a thin
ventricular wall (Figure 2C). There was a clear reduction
of LV myocardial motion on Doppler tissue imaging to
4 mm/s (Figure 2D). Immediate treatment involved insertion
of a temporary cardiac pacemaker; this was succeeded by
b-adrenergic blocker maintenance therapy.
Family pedigree
Subject I-2 had a history of multiple episodes of syncopy at
an age ,55 years, but not at ages beyond this. The 12-lead
ECGs revealed borderline PR intervals (200 ms) and QRS dur-
ations (120 ms), LAFB, prolonged QTc intervals (550 ms) with
a signiﬁcant leftward shift of the electrical axis. Echocardio-
graphic examination demonstrated a LVEDV of 188 mL, a
LVESV of 124 mL and an EF of 34% (Table 1). Subject II-4,
the proband’s father had already died suddenly at 33 years
of age during a Valsalva manoeuvre despite having no
history of syncope. Subject II-1, one of the proband’s
aunts had died suddenly at age 13 years after an angry argu-
ment. Subjects II-1, II-3, II-5, II-6, III-1, and III-3 appeared
normal with no history of syncope, sudden death, or cardio-
vascular events. The 12-lead ECG’s revealed normal QTc
intervals and transthoracal echocardiography revealed
normal cardiac structure and function. None of the subjects
fulﬁlled criteria for arrhythmogenic right ventricular dys-
plasia. Table 1 shows a summary of ECG, echocardiography
parameters, and clinical information about the live members
of the family pedigree.
Genetic analysis
A heterozygous deletion of nine base pairs (CAGAAGCCC) in
exon 26 of SCN5A (Figure 3A), corresponding to the three
amino acid residues Gln1507–Lys1508–Pro1509 (QKP) was
found (Figure 3B) in the proband (subject III-2) and his
grandmother (subject I-2) and excluded in the remaining
living subjects in this family. This mutation was conﬁrmed
using SSCP (Figure 3C). The inframe-deletion disrupts the
coding sequence of QKP at the terminal part of exon 26
and is localized in the linker region between DIII and DIV
of the Nav1.5 sodium channel (Figure 3D). Similar analysis
excluded possible mutations that would lead to amino acid
changes in KCNQ1, HERG, and LAMIN A/C commonly associ-
ated with LQT1, LQT2, and DCM with conduction disorders
on earlier occasions:
11–13 we did not ﬁnd new mutations
that would lead to amino acid changes. Three base substi-
tutions were observed in HERG: 1480C!T, 1552C!T, and
1705A!G, but these would not have altered the encoded
amino acid.
Discussion
This paper associates multiple clinical cardiac phenotypes
with the gain-of-function, delQKP1507–1509 sodium channel
mutation, inthe linker region between DIIIand DIV, associated
with channel inactivation, for the ﬁrst time. This adds to
previous reports and identiﬁcations of this mutation through
three generations of a family pedigree that had then observed
only a single, LQT3, phenotype.
9 Previous biophysical studies
of this delQKP1507–1509 mutation had revealed persistent
residual sodium currents that were 1–1.5% of the maximum
current magnitude measured at 230 mV nearly completely
blocked by the sodium-channel blockers, tetrodotoxin and
lidocaine. These ﬁndings were additionally associated with
signiﬁcantpositiveshiftsof steady-stateactivation
9 and nega-
tive shifts in inactivation.
9 Such features correlated with a
LQT phenotype, consistent with previous studies of other
SCN5A mutations causing LQTS.
7,15–17 However, persistent
inward currents associated with LQT-related mutations have
also been reported to result in bradycardia and sinus pauses
resulting from sinoatrial node cells failing to repolarize
under conditions of extra net inward current suggesting the
possibility of additional phenotypic characteristics.
18 The
present clinical report fulﬁlls such biophysical predictions.
These ﬁndings also complement other reports that single
sodium channel mutations can result in multiple phenotypes
givingrisetoan ‘overlapsyndrome’ as wellas uniqueisolated
phenotypes in which a mutation expected to result in a
gain-of-function results in phenotypes that include changes
suggestive instead of a loss-of-function.
19–22 Thus, the
C-terminal SCN5A mutation (1795insD) is associated with
Table 1 Summary of electrocardiographic, echocardiography parameters, and clinical information of live members of the family pedigree
Subject Sex Age (years) HR (bmp) PR interval (ms) QRS duration (ms) QTc (ms) LEVDV (mL) LEVSV (mL) EF (%)
I-1 M 68 58 200 100 400 122 50 59
I-2 F 65 88 200 120, LAFB 550 188 124 34
II-2 F 44 71 160 80 430 101 38 62
II-4 F 40 65 120 90 430 106 41 61
II-6 F 35 70 140 90 430 88 32 64
III-1 M 18 75 160 100 440 92 34 64
III-2 F 13 92 120 100; LAFB; IRBBB 750 156 98 37
III-3 F 11 73 140 90 430 136 54 60
LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LAFB, left anterior fascicular block; IRBBB, incomplete right
bundle-branch block; EF, ejection fraction. Simpson’s method was used to record the data.
R. Shi et al. 1332Figure 3 delQKP1507–1509 mutation of SCN5A sodium channel. (A) A heterozygous deletion of nine base pairs (CAGAAGCCC) in exon 26 of
SCN5A resulting in the deletion of three amino acids QKP Gln1507–Lys1508–Pro1509 compared with the corresponding control segments
(B) of exon 26 of SCN5A.( C) SSCP conﬁrmed two mutation carriers (proband and subject I-2). No labelled bands are control samples.
(D) Position of the delQKP1507–1509 mutation on Nav1.5 channel.
Expanding spectrum of cardiac sodium channel mutation Delqkp 1507–1509 1333several clinical ECG features of bradycardia, conduction
disease, LQT3, and BrS.
23,24 There is a similar bradycardia,
right ventricular conduction slowing, and QT prolongation
in the corresponding Scn5a1798insD/þ murine model,
25
which shows 39% reductions in peak sodium current density
resulting in a similar reduction in action potential upstroke
velocity accounting for conduction disorder; delays in fast
inactivation, and persistent sodium currents resulting in
action potential prolongation. The persistent inward
current may also account for the observed bradycardia and
sinus pauses resulting from sinoatrial node cells failing to
repolarize under conditions of extra net inward current.
18
Similarly, patients carrying a deletion of a lysine in the
intracellular DIII–DIV linker (delK1500), located close to
the LQT3-associated mutation delKPQ1505–1507, have also
been shown to display a heterogeneous clinical phenotype
with symptoms of long-QT syndrome, BrS, and conduction
disease.
21
However, there have been relatively few clinical reports
associating Na
þ channel abnormalities with DCM, most
strikingly observed in 13-year-old proband, and all of these
have consistently resulted in loss- rather than gain-of- func-
tion.
26 Olson et al. localized a form of congenital DCM
(CMD1E) characterized by progression toward atrial dilata-
tion, frequently followed by right and, sometimes left
ventricular dilatation and dysfunction
27 to a heterozygous
mutation (3823 G!A) in exon 21 leading to a D1275N
substitution in the S3 transmembrane region of domain III
of SCN5A.
6 This had previously been mapped to chromo-
some 3p22–p25.
28 It resulted in a þ3.8 mV shift in sodium
conductance activation curves in a Xenopus oocyte
expression system.
4 A more extensive analysis then identi-
ﬁed 156 unrelated DCMpatients negative for mutations in
other associated genes including those encoding cardiac
actin, a-tropomyosin, and metavinculin. However, they
showed alterations in four highly conserved residues in
the transmembrane domains of SCN5A. Such patients
also showed a range of phenotypes including SSS, atrial
and ventricular arrhythmias, and congenital conduction
disease. In contrast, the present ﬁndings associated DCM
with a gain-of-function, delQKP1507–1509, mutation for
the ﬁrst time.
In summary, the present study identiﬁed a gain-of-
function, delQKP, mutation at position 1507–1509 of the
cardiac sodium channel in a three generation Chinese
family associated with an expanded spectrum of disorder:
LQT3, cardiac conduction defects, DCM and high incidence
of youth sudden death. These data compliment previous
reports of an expanding spectrum of phenotypes of this
known mutation, as well as associating the DCM phenotype
with gain-of-function sodium channel mutations for the
ﬁrst time.
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